Skip to main content
Caplight Logo









Temedica

Temedica

Private
MunichHealthcare & Life Scienceshttps://temedica.com/

Last Round

Series B

Extension

Nov 23, 2022

Total Funding Raised

$44.8M

Company Overview

Temedica is a health-tech company that provides a real-world insights ecosystem with a data analytics platform and patient companion apps for the pharmaceutical industry.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Healthcare Analytics, Vertical SaaS

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Application

Keywords

real-world evidenceRWEpatient support programsdigital healthpatient-reported outcomesPROhealth techpatient engagementhealthcare analyticsdata as a serviceDaaSvertical SaaSpatient adherenceelectronic medical recordsEMR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Temedica Comparables

Compare Temedica with similar companies based on industry and business-model similarity.

Temedica comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
XO Life
85%
mama health technologies GmbH
80%
Evidation
78%

Temedica Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionNov 23, 2022
Series BJan 15, 2020
SeedDec 8, 2017
SeedOct 1, 2016

Key People

Founding team and executive leadership

PD Dr. med Benjamin Friedrich

Chief Medical Officer Co-Founder

Founding Team

Moritz Seuster

Chief Executive Officer

Executive Team

David Newlands

Chief Financial Officer

Executive Team

Alexandru Dina-Gargala

Chief Product & Technology Officer

Executive Team

Temedica Investors

Notable investors and investment history

Temedica investors
InvestorRounds
SalviaSeries B
MIG CapitalSeries B, Series B Extension
BayStartUPSeed
G+J Digital VenturesSeries B
Santo Venture CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 8, 2017

    Seed round raised with participation from BayStartUP.

Temedica Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Temedica Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Temedica's valuation, stock price, and market status.

Firmographic Details

HeadquartersMunich
Employee Range67
Year Founded2016
Last FundingNov 23, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?